Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Considerations for commonly prescribed medications by dermatologists in patients on immune checkpoint inhibitors.
Journal: Journal of the American Academy of Dermatology
Published: February 22, 2026
Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLC.
Journal: NPJ precision oncology
Published: August 20, 2025
Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery.
Journal: Pathology oncology research : POR
Published: May 02, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 05, 2023
Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung Cancer.
Journal: Cancers
Published: December 31, 2022
Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer.
Journal: Frontiers in oncology
Published: December 05, 2022
Tissue-agnostic RET inhibition: can you trust your target?
Journal: The Lancet. Oncology
Published: September 01, 2022
Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban Population.
Journal: Journal of gastrointestinal cancer
Published: April 27, 2022
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting.
Journal: Stem cell investigation
Published: January 25, 2021
Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort.
Journal: Cancers
Published: January 09, 2021
Last Updated: 09/26/2026